Mingyi Chen

10.4k citations

198 papers · 6.5k indexed · 3 hit papers · h-index 41

Impact in

Immunology top 1%
- Atherosclerosis and Cardiovascular Diseases
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- Drug Transport and Resistance Mechanisms

Papers in ⓘ

Hematology 33
- Acute Myeloid Leukemia Research 13
Immunology 42
- Immune Cell Function and Interaction 17
- Atherosclerosis and Cardiovascular Diseases 11
- Immunotherapy and Immune Responses 11

Co-authors: Tatsuya Sawamura (11 shared papers)Τοmoh Masaki (9 shared papers)Hongwei Guo (17 shared papers)Peter Tontonoz (5 shared papers)Haitao He (6 shared papers)William J. Murphy (23 shared papers)Shuh Narumiya (4 shared papers)Arta M. Monjazeb (14 shared papers)
Journals: Blood (17 papers)Seminars in Diagnostic Pathology (7 papers)Proceedings of the National Academy of Sciences (6 papers)American Journal of Clinical Pathology (5 papers)Cancers (3 papers)
Partner nations: United States China Japan

In The Last Decade

Mingyi Chen

184 papers receiving 6.4k citations

Hit Papers

align trajectories log scale

Severely polarized extracellular acidity around tumour cells 2024 · 80 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2024 Nature Biomedical Engineering
2020 Nature Communications
2002 Proceedings of the National Academy of Sciences

Peers

Countries citing papers authored by Mingyi Chen

Since Specialization

Citations

This map shows the geographic impact of Mingyi Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingyi Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingyi Chen more than expected).

Fields of papers citing papers by Mingyi Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingyi Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingyi Chen. The network helps show where Mingyi Chen may publish in the future.

Co-authors

The 25 scholars most cited alongside Mingyi Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mingyi Chen Line = papers co-authored together Mingyi Chen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 198 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Synthetic LXR ligand inhibits the development of atherosclerosis in mice Proceedings of the National Academy of Sciences ·Sean B. Joseph, Elaine McKilligin, Liming Pei, Michael A. Watson, Alan R. Collins, Bryan Laffitte, Mingyi Chen, Grace Noh, Joanne Goodman, Graham N. Hagger, Jonathan Tran, Tim K. Tippin, Xuping Wang, Aldons J. Lusis, Willa A. Hsueh, Ronald E. Law, Jon L. Collins, Timothy M. Willson, Peter Tontonoz Hit paper breakdown →	2002	778
2	PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade Nature Communications ·Peng Qi, Xiangyan Qiu, Zihan Zhang, Silin Zhang, Yuanyuan Zhang, Yong Liang, Jingya Guo, Hua Peng, Mingyi Chen, Yang‐Xin Fu, Haidong Tang Hit paper breakdown →	2020	370
3	LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis Pharmacology & Therapeutics ·Mingyi Chen, Τοmoh Masaki, Tatsuya Sawamura	2002	318
4	Gamma correction for digital fringe projection profilometry Applied Optics ·Hongwei Guo, Haitao He, Mingyi Chen	2004	258
5	A role for the apoptosis inhibitory factor AIM/Spα/Api6 in atherosclerosis development Cell Metabolism ·Satoko Arai, John M. Shelton, Mingyi Chen, Michelle N. Bradley, Antonio Castrillo, Angie L. Bookout, Puiying A. Mak, Peter A. Edwards, David J. Mangelsdorf, Peter Tontonoz, Toru Miyazaki	2005	242
6	Intake of Ganoderma lucidum polysaccharides reverses the disturbed gut microbiota and metabolism in type 2 diabetic rats International Journal of Biological Macromolecules ·Mingyi Chen, Dan Xiao, Wen Liu, Yunfei Song, Baorong Zou, Lin Li, Pei Li, Ying Cai, Deliang Liu, Qiongfeng Liao, Zhi Xie	2019	182
7	NK Cells Preferentially Target Tumor Cells with a Cancer Stem Cell Phenotype The Journal of Immunology ·Erik Ames, Robert J. Canter, Steven K. Grossenbacher, Stephanie Mac, Mingyi Chen, Rachel Smith, Takeshi Hagino, Jessica Perez-Cunningham, Gail D. Sckisel, Shiro Urayama, Arta M. Monjazeb, Rubén Fragoso, Thomas J. Sayers, William J. Murphy	2015	181
8	Increased Expression of Lectinlike Oxidized Low Density Lipoprotein Receptor-1 in Initial Atherosclerotic Lesions of Watanabe Heritable Hyperlipidemic Rabbits Arteriosclerosis Thrombosis and Vascular Biology ·Mingyi Chen, Makoto Kakutani, Manabu Minami, Hiroharu Kataoka, Noriaki Kume, Shuh Narumiya, Toru Kita, Τοmoh Masaki, Tatsuya Sawamura	2000	162
9	MLH1 Deficiency-Triggered DNA Hyperexcision by Exonuclease 1 Activates the cGAS-STING Pathway Cancer Cell ·Junhong Guan, Changzheng Lu, Qihuang Jin, Huiming Lu, Xiang Chen, Lei Tian, Yanbin Zhang, Janice Ortega, Junqiu Zhang, Silvia Siteni, Mingyi Chen, Liya Gu, Jerry W. Shay, Anthony J. Davis, Zhijian J. Chen, Yang‐Xin Fu, Guo‐Min Li	2020	161
10	Activation-Dependent Surface Expression of LOX-1 in Human Platelets Biochemical and Biophysical Research Communications ·Mingyi Chen, Makoto Kakutani, Takahiko Naruko, Makiko Ueda, Shuh Narumiya, Τοmoh Masaki, Tatsuya Sawamura	2001	131
11	The Phospholipid Transfer Protein Gene Is a Liver X Receptor Target Expressed by Macrophages in Atherosclerotic Lesions Molecular and Cellular Biology ·Bryan Laffitte, Sean B. Joseph, Mingyi Chen, Antonio Castrillo, Joyce J. Repa, Damien C. Wilpitz, David J. Mangelsdorf, Peter Tontonoz	2003	129
12	Ferredoxin reductase is critical for p53-dependent tumor suppression via iron regulatory protein 2 Genes & Development ·Yanhong Zhang, Yingjuan Qian, Jin Zhang, Wensheng Yan, Yong-Sam Jung, Mingyi Chen, Eric C. Huang, K. C. Kent Lloyd, Yuyou Duan, Jian Wang, Gang Liu, Xinbin Chen	2017	121
13	Aging predisposes to acute inflammatory induced pathology after tumor immunotherapy The Journal of Experimental Medicine ·Myriam N. Bouchlaka, Gail D. Sckisel, Mingyi Chen, Annie Mirsoian, Anthony E. Zamora, Emanual Maverakis, Danice Wilkins, Kory L. Alderson, Hui-Hua Hsiao, Jonathan M. Weiss, Arta M. Monjazeb, Charles Hesdorffer, Luigi Ferrucci, Dan L. Longo, Bruce R. Blazar, Robert H. Wiltrout, Doug Redelman, Dennis D. Taub, William J. Murphy	2013	117
14	Diabetes Enhances Lectin-like Oxidized LDL Receptor-1 (LOX-1) Expression in the Vascular Endothelium: Possible Role of LOX-1 Ligand and AGE Biochemical and Biophysical Research Communications ·Mingyi Chen, Miki Nagase, Toshiro Fujita, Shuh Narumiya, Τοmoh Masaki, Tatsuya Sawamura	2001	115
15	Huang-Lian-Jie-Du-Decoction Ameliorates Hyperglycemia and Insulin Resistant in Association With Gut Microbiota Modulation Frontiers in Microbiology ·Mingyi Chen, Ziqiong Liao, Biyu Lu, Mengxia Wang, Lin Lei, Shaobao Zhang, Yuan Li, Deliang Liu, Qiongfeng Liao, Zhi Xie	2018	108
16	LOX‐1 mediates lysophosphatidylcholine‐induced oxidized LDL uptake in smooth muscle cells FEBS Letters ·Takuma Aoyama, Mingyi Chen, Hisayoshi Fujiwara, Τοmoh Masaki, Tatsuya Sawamura	2000	99
17	Radiotherapy enhances natural killer cell cytotoxicity and localization in pre-clinical canine sarcomas and first-in-dog clinical trial Journal for ImmunoTherapy of Cancer ·Robert J. Canter, Steven K. Grossenbacher, Jennifer A. Foltz, Ian R. Sturgill, Jiwon S. Park, Jesus I. Luna, Michael S. Kent, William T. N. Culp, Mingyi Chen, Jaime F. Modiano, Arta M. Monjazeb, Dean Lee, William J. Murphy	2017	97
18	Adiposity induces lethal cytokine storm after systemic administration of stimulatory immunotherapy regimens in aged mice The Journal of Experimental Medicine ·Annie Mirsoian, Myriam N. Bouchlaka, Gail D. Sckisel, Mingyi Chen, Chien-Chun Steven Pai, Emanual Maverakis, Richard G. Spencer, Kenneth W. Fishbein, Sana Siddiqui, Arta M. Monjazeb, Bronwen Martin, Stuart Maudsley, Charles Hesdorffer, Luigi Ferrucci, Dan L. Longo, Bruce R. Blazar, Robert H. Wiltrout, Dennis D. Taub, William J. Murphy	2014	97
19	Blocking Indolamine-2,3-Dioxygenase Rebound Immune Suppression Boosts Antitumor Effects of Radio-Immunotherapy in Murine Models and Spontaneous Canine Malignancies Clinical Cancer Research ·Arta M. Monjazeb, Michael S. Kent, Steven K. Grossenbacher, Christine Mall, Anthony E. Zamora, Annie Mirsoian, Mingyi Chen, Amir Kol, Stephen L. Shiao, Abhinav Reddy, Julian R. Perks, William T. N. Culp, Ellen E. Sparger, Robert J. Canter, Gail D. Sckisel, William J. Murphy	2016	91
20	Canine cancer immunotherapy studies: linking mouse and human Journal for ImmunoTherapy of Cancer ·Jiwon S. Park, Sita S. Withers, Jaime F. Modiano, Michael S. Kent, Mingyi Chen, Jesus I. Luna, William T. N. Culp, Ellen E. Sparger, Robert B. Rebhun, Arta M. Monjazeb, William J. Murphy, Robert J. Canter	2016	87

About Mingyi Chen

Mingyi Chen is a scholar working on Hematology, Immunology, Oncology, Computer Vision and Pattern Recognition and Genetics, having authored 198 papers that have together received 6.5k indexed citations. Recurring topics across this work include Optical measurement and interference techniques (31 papers), Advanced Measurement and Metrology Techniques (24 papers), Immune Cell Function and Interaction (17 papers), Acute Myeloid Leukemia Research (13 papers), RNA modifications and cancer (13 papers), RNA Research and Splicing (11 papers), Atherosclerosis and Cardiovascular Diseases (11 papers) and Immunotherapy and Immune Responses (11 papers). The work is most often cited by research in Immunology (2.3k citations), Oncology (1.7k citations), Cancer Research (682 citations), Computer Vision and Pattern Recognition (657 citations) and Molecular Biology (2.1k citations). Mingyi Chen has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Tatsuya Sawamura, Τοmoh Masaki, Hongwei Guo, Peter Tontonoz, Haitao He, William J. Murphy, Shuh Narumiya, Arta M. Monjazeb, Sean B. Joseph and Bryan Laffitte. Their work appears in journals such as Blood, Seminars in Diagnostic Pathology, Proceedings of the National Academy of Sciences, American Journal of Clinical Pathology and Cancers.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact